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Although dramatic progress has been made in understanding the pathogenesis of 
neurodegenerative conditions of the aged population such as Alzheimer's disease, 
Parkinson's disease and Fronto-Temporal dementia, to date most of these diseases are 
incurable. Because of the aging population, these disorders pose a serious challenge to the 
health care system. Loss of synapses is probably the common neuropathological feature 
leading to dementia in these neurodegenerative disorders.
1
 
Parkinson's disease  is a progressive neurodegenerative condition caused by loss of 
dopamine producing cells in the substantia located in the basal ganglia causing motor, 
autonomic and cognitive impairments.
2
 Rasagiline is a potent, selective, irreversible inhibitor 
of monoamine oxidase (MAO) which is an anti-Parkinson drug.
3
 
Herein, we present our innovative approach to the synthesis of several chiral amine
4  
-benzolactam analogues which involves a one-pot borylation-Imination-Arylation (BoImAr) 
sequence - the last step being a key intramolecular catalytic arylation reaction (Scheme 1). 
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